Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Finding a travel credit card with no annual fee can be rewarding. Learn what features matter most to maximize your travel benefits.
19,501 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
A federal judge sent Nevada's cases against Kalshi and Polymarket back to state court, opening the door for temporary...
Kickstarter’s stands 4-day workweek, a bold move for a remote-first company. The CEO says it balances life with high ...
NVIDIA will begin counting stock-based compensation in non-GAAP results from Q1 FY2027, a shift that rekindles a long...
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
Stratasys beat on both earnings and revenue, yet stratasys stock just crashed as investors weighed guidance and marke...
When money stress hits, any scar—literal or figurative—can remind us that growth comes from resilience. This piece ex...
Whispers of a Caesars takeover are fueling a strong price on Kalshi. This article explains what a 68% probability mea...
Large XRP holders are stepping up activity while on-chain metrics show renewed buying interest. Analysts say the XRP/...
Oracle leads data center stocks this week as AI cloud momentum outpaces rivals CoreWeave and Applied Digital in a vol...
Rezervology and Titl unveil RezeLink, an AI-native platform designed to speed title searches for SoftPro users, boast...
NIO and LI AUTO report divergent Q3 2025 results: NIO accelerates with a multi-brand push, while LI AUTO trims extend...